Goleta, CA, United States of America

Kazuki Sugahara

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 54(Granted Patents)


Location History:

  • Goleta, CA (US) (2013 - 2022)
  • La Jolla, CA (US) (2020 - 2022)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Kazuki Sugahara

Introduction

Kazuki Sugahara is a prominent inventor based in Goleta, California. With a remarkable portfolio of ten patents, Sugahara has contributed significantly to the fields of biotechnology and molecular biology, particularly in the development of targeted delivery systems for therapeutic applications.

Latest Patents

Among Sugahara's latest patents are innovative methods and compositions that utilize peptides and proteins with c-terminal elements. These compositions and methods are specifically designed for the targeted internalization of molecules into cells and their penetration into tissues of interest. Such advancements are essential for effectively delivering therapeutic and detectable agents to the desired cells and tissues. Another significant patent focuses on targeted delivery systems and therapeutic methodologies. This patent discloses various peptides, including sequences such as KRGARST, AKRGARSTA, and CKRGARSTC, and outlines innovative methods for directing and imaging tumor lymphatic vasculature as well as for treating cancer and associated disorders.

Career Highlights

Kazuki Sugahara has made a lasting impact during his tenure at renowned institutions, including the Sanford Burnham Medical Research Institute and Sanford Burnham Prebys Medical Discovery Institute. His work at these organizations has facilitated cutting-edge research and has contributed to significant advancements in understanding and treating diseases.

Collaborations

Throughout his career, Sugahara has collaborated with esteemed colleagues such as Erkki I. Ruoslahti and Tambet Teesalu. These collaborations have fostered innovation and have enhanced the scope of research projects, leading to groundbreaking discoveries in peptide and protein-based therapies.

Conclusion

Kazuki Sugahara continues to be a driving force in the field of biotechnology, with his patents paving the way for new therapeutic approaches and improved understanding of cellular functions. His innovative spirit and dedication to research exemplify the transformative power of inventions in science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…